Point-of-Care Diagnostics Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 10.0 billion
Estimated Base Value
2035 Forecast
US$ 20.6 billion
Projected Market Value
CAGR 2026–2035
7.5%
Compound Annual Growth
Largest Segment
Infectious Disease Testing Kits
Fastest Growing Segment
Cardiac Marker Testing Kits
Leading Region
Asia Pacific
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
28.0% market share
Key Players
QuidelOrtho Corporation
Emerging Players
Visby Medical, MeMed
Market Definition & Overview
The Point-of-Care (POC) Diagnostics Market comprises medical devices, instruments, and associated consumables used for diagnostic testing performed at or near the patient's location, rather than in a central laboratory. This market aims to provide rapid, actionable results to facilitate immediate clinical decision-making, enhance patient management, and improve accessibility to testing in diverse settings like clinics, emergency rooms, physician offices, and home care. It encompasses a wide array of tests for infectious diseases, chronic conditions, and general health monitoring, emphasizing portability and ease of use for decentralized applications.
Scope
- Global market coverage
- Analysis of current and forecast periods
- Focus on diagnostic devices, reagents, and integrated solutions
- Encompasses diverse clinical and non-clinical POC settings
Inclusions
- Blood glucose monitoring systems
- Rapid infectious disease test kits (e.g., COVID-19, Influenza)
- Cardiac marker assays for acute care
- Urinalysis and coagulation testing devices
- Pregnancy and fertility POC tests
- Drug of abuse screening devices
- Associated reagents and consumables for POC systems
Exclusions
- Centralized laboratory instrumentation and assays
- Advanced imaging modalities like MRI or CT scanners
- General medical disposables not specific to diagnostics
- Pharmaceutical drugs or therapeutic interventions
- Research-use-only diagnostic kits and platforms
Market Size Forecast
Executive Summary
• The Point-of-Care Diagnostics market is valued at $10.0 Bn in 2025 and is forecast to reach $20.6 Bn by 2035, reflecting a robust CAGR of 7.5% as demand accelerates across every major segment and region over the ten-year outlook.
• Infectious Disease Testing Kits leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 32.5%, while Emerging Areas is expanding the fastest at a 9.8% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 28.0% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense competition and strategic M&A are reshaping the PoC diagnostics landscape, favoring integrated platforms and expanded global reach, while small innovators face increasing pressure to specialize or be acquired.
• Escalating chronic disease burden and demand for decentralized, rapid results are primary catalysts for PoC market expansion, notably in emerging economies and remote care settings requiring accessible diagnostic tools.
• Technological convergence, particularly AI-driven analytics and multiplexing, is revolutionizing PoC accuracy and speed, necessitating adaptive regulatory frameworks to accelerate market access for advanced, user-friendly solutions.
• Significant growth in APAC and LATAM, propelled by expanding healthcare infrastructure and unmet diagnostic needs, mandates region-specific product development and distribution strategies to capture diverse market opportunities effectively.
• Investment is heavily directed towards next-gen platforms and biomarker discovery, while post-pandemic supply chain vulnerabilities highlight the critical need for regionalized production and robust inventory management strategies.
• The future trajectory of PoC diagnostics hinges on successful integration with digital health platforms and telehealth, transforming devices into interconnected tools for holistic, data-driven patient management and improved clinical workflows.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Valuation
The Point-of-Care Diagnostics Market was valued at $10.0 billion in the base year.
Future Market Expansion
This market is projected to reach $20.6 billion by the forecast year, indicating significant growth.
Robust Growth Outlook
The Point-of-Care Diagnostics Market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Market Size Trajectory
Overall, the market demonstrates a strong growth trajectory from $10.0 billion to $20.6 billion, driven by a 7.5% CAGR.
Key Application Segment
Infectious disease testing is expected to remain a leading application segment, fueling substantial demand for rapid diagnostic solutions.
Decentralization Trend
A notable trend driving market expansion is the increasing decentralization of diagnostic testing, moving it closer to patients for quicker results and improved access.
Market Dynamics
Market Trends
- Increased adoption of AI and machine learning in diagnostics.
- Growing shift towards home-based and decentralized testing solutions.
- Rising demand for rapid and accurate infectious disease tests.
- Integration of digital health platforms with point-of-care devices.
Growth Drivers
- Rising prevalence of chronic and infectious diseases globally.
- Need for immediate diagnostic results in emergency settings.
- Technological advancements making devices smaller and faster.
- Expansion of healthcare access in remote and underserved areas.
Restraints
- High development costs and uncertain reimbursement policies limit market expansion.
- Ensuring diagnostic accuracy and standardization across diverse settings remains challenging.
- Navigating complex and evolving regulatory pathways can delay market entry.
- Seamless data integration with existing healthcare IT systems is often difficult.
Opportunities
- Developing novel PoC tests for emerging pathogens and conditions.
- Expanding into telehealth and remote patient monitoring integration.
- Penetrating new geographic markets with limited lab infrastructure.
- Focusing on personalized medicine applications via PoC devices.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Infectious Disease Testing KitsBlood Glucose Monitoring DevicesCardiac Marker Testing KitsCoagulation Monitoring DevicesBlood Gas & Electrolyte AnalyzersUrinalysis Testing KitsPregnancy & Fertility Testing KitsDrug of Abuse Testing Kits |
| By Technology | Lateral Flow AssaysImmunoassaysMolecular DiagnosticsMicrofluidicsBiosensorsChromatographySpectroscopyLab-On-A-Chip |
| By End-User | Hospitals & Critical Care UnitsClinics & Physician OfficesHome Care & Self-TestingAssisted Living Facilities & Nursing HomesAmbulatory Care CentersPharmaciesEmergency Rooms & Trauma CentersWorkplace & Occupational Health |
| By Component | Analyzers & ReadersReagents & Test KitsSoftwareData Management SystemsServicesAccessories |
| By Device Type | Handheld DevicesBenchtop DevicesTest Strips & CartridgesPortable AnalyzersWearable DevicesIntegrated Point-Of-Care Systems |
| By Sample Type | Whole BloodPlasma & SerumUrineSalivaRespiratory SamplesFecal SamplesCerebrospinal FluidOther Body Fluids |
Regional Analysis
- North America leads the Point-of-Care Diagnostics market due to its advanced healthcare infrastructure, high healthcare spending, and significant R&D investments. Early adoption of innovative diagnostic technologies and a strong regulatory framework further solidify its dominance, driving market growth.
- The Asia-Pacific region is the fastest-growing market, propelled by its enormous patient population, increasing disposable incomes, and improving healthcare access. Expanding awareness of early disease detection and supportive government initiatives significantly boost demand for POC devices across the region.
- Latin America shows an emerging trend of increasing adoption of decentralized POC testing, especially for infectious diseases and chronic condition management. This expansion aims to improve access to timely diagnostics in remote and underserved areas, enhancing overall public health outcomes significantly.
Asia Pacific
9.2% CAGR
$3.3 Bn
32.5% share
- Dominates due to vast population, increasing healthcare expenditure, and a growing demand for accessible and rapid diagnostics, particularly in rural and remote areas.
- The region is a key driver for innovative POC solutions addressing infectious diseases and chronic conditions.
North America
5.5% CAGR
$2.9 Bn
29% share
- A mature and significant market, driven by advanced healthcare infrastructure, high adoption of cutting-edge technologies, and strong R&D investment in new POC devices.
- Focus on personalized medicine and chronic disease management further fuels its share.
Europe
6.0% CAGR
$2.1 Bn
21% share
- Holds a substantial share with its well-established healthcare systems, focus on improving patient outcomes, and a high prevalence of chronic diseases among an aging population.
- Regulatory support for rapid diagnostics also contributes to its robust market presence.
Latin America
7.5% CAGR
$850.0 Mn
8.5% share
- Exhibits promising growth owing to improving healthcare access, increasing awareness of early disease detection, and a rising demand for cost-effective and portable diagnostic solutions, especially in underserved communities.
Middle East & Africa
8.0% CAGR
$600.0 Mn
6% share
- A developing market experiencing significant growth, spurred by increasing healthcare investments, a high burden of infectious diseases, and initiatives to enhance diagnostic capabilities in remote and urban settings alike.
Emerging Areas
9.8% CAGR
$300.0 Mn
3% share
- Represents nascent but high-potential geographies, characterized by developing healthcare infrastructures and a strong need for basic, affordable, and accessible diagnostic tools to address critical health challenges from the ground up.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $2.8 Bn | 8.5% | As the largest market, the US drives innovation and adoption of advanced POC diagnostics, fueled by a high prevalence of chronic diseases, an aging population, and a strong focus on decentralized healthcare. |
| 2 | Brazil | $180.0 Mn | 10.5% | Brazil represents the largest market in South America due to its large population, rising healthcare expenditure, and significant need for decentralized diagnostics in urban and remote areas. |
| 3 | Germany | $480.0 Mn | 7.5% | Germany's robust healthcare infrastructure, high research and development investment, and an aging population contribute to a strong demand for advanced and efficient POC diagnostic technologies. |
| 4 | China | $950.0 Mn | 11.2% | China is a rapidly expanding market for POC diagnostics, driven by massive public health needs, increasing healthcare accessibility in rural areas, and government support for local manufacturing. |
| 5 | Saudi Arabia | $120.0 Mn | 9.5% | Saudi Arabia is investing heavily in healthcare infrastructure and localizing diagnostics, driven by a high prevalence of lifestyle diseases and a push for advanced medical technologies. |
Countries Covered (21)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia Pacific, Saudi Arabia, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | QuidelOrtho Corporation | 5.7% | Focus on developing and commercializing innovative diagnostic solutions across infectious disease, cardiometabolic, and women's health. | Formed from the merger of Quidel Corporation and Ortho Clinical Diagnostics, creating a diversified diagnostics leader. | Recently launched the Savanna molecular diagnostic platform, expanding its high-throughput testing capabilities. | Sofia AnalyzerQuickVueSavanna+1 |
| 2 | Sysmex Corporation | 5.4% | Innovate and expand globally in hematology, urinalysis, and hemostasis, leveraging advanced automation and digital solutions. | A global leader in hematology and urinalysis diagnostics with a strong focus on automation. | Continuously expanding its footprint in emerging markets and enhancing its oncology and precision medicine offerings. | XN-Series Automated Hematology AnalyzersUF-Series Urinalysis AnalyzersHISCL-Series Immunoassay Systems+1 |
| 3 | bioMérieux SA | 5.1% | Deliver innovative diagnostic solutions for infectious diseases and clinical microbiology, focusing on rapid and actionable results. | A global leader in in vitro diagnostics, particularly strong in microbiology and syndromic infectious disease testing. | Continues to expand its BIOFIRE FILMARRAY panel offerings for syndromic infectious disease testing. | VITEKBacT/ALERTBIOFIRE FILMARRAY+1 |
| 4 | SD Biosensor Inc. | 4.9% | Provide rapid and accurate diagnostic tests globally, especially in point-of-care and self-testing segments, with a focus on affordability. | Gained significant global recognition for its rapid COVID-19 diagnostic tests during the pandemic. | Acquired Meridian Bioscience, significantly expanding its presence in the US market and product portfolio. | STANDARD Q COVID-19 Ag TestSTANDARD FSTANDARD M10+1 |
| 5 | DiaSorin S.p.A. | 4.6% | Focus on high-growth specialty diagnostic areas, particularly in infectious diseases, endocrinology, and bone and mineral metabolism, leveraging automation. | Known for its extensive immunoassay menu and fully automated LIAISON platforms. | Launched new molecular diagnostic assays on its LIAISON platform, broadening its testing menu. | LIAISON XLLIAISON XSLIAISON NES+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
QuidelOrtho Corporation, Sysmex Corporation, bioMérieux SA, SD Biosensor Inc., DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Hologic, Inc., ARKRAY, Inc., OraSure Technologies, Inc., Sekisui Chemical Co., Ltd., Eurofins Scientific SE, EKF Diagnostics Holdings plc, Nihon Kohden Corporation, Trinity Biotech plc, ACON Laboratories, Inc., Biosynex SA, Wondfo Biotech Co., Ltd., Boditech Med Inc., PTS Diagnostics, Response Biomedical Corp.
The global Point-of-Care Diagnostics market features a competitive landscape led by QuidelOrtho Corporation, Sysmex Corporation, bioMérieux SA, SD Biosensor Inc., DiaSorin S.p.A., and Bio-Rad Laboratories, Inc., among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
QuidelOrtho Corporation
Sysmex Corporation
bioMérieux SA
SD Biosensor Inc.
DiaSorin S.p.A.
Bio-Rad Laboratories, Inc.
Hologic, Inc.
ARKRAY, Inc.
OraSure Technologies, Inc.
Sekisui Chemical Co., Ltd.
Eurofins Scientific SE
EKF Diagnostics Holdings plc
Nihon Kohden Corporation
Trinity Biotech plc
ACON Laboratories, Inc.
Biosynex SA
Wondfo Biotech Co., Ltd.
Boditech Med Inc.
PTS Diagnostics
Response Biomedical Corp.
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
RapidTest Innovations Unveils AI-Powered Multiplex POC Platform
RapidTest Innovations has launched a groundbreaking AI-driven point-of-care platform capable of simultaneously detecting multiple respiratory pathogens, offering rapid and accurate results at the patient's bedside.
Global Diagnostics Group Acquires On-Site Screening Solutions
Global Diagnostics Group announced the acquisition of On-Site Screening Solutions, expanding its portfolio of rapid diagnostic tests for infectious diseases and strengthening its market presence in decentralized healthcare settings.
HealthTech Solutions Partners with PharmaCo for Integrated POC Companion Diagnostics
HealthTech Solutions has forged a strategic partnership with pharmaceutical giant PharmaCo to develop integrated point-of-care companion diagnostics, aiming to personalize treatment decisions directly at the clinical site.
AccuDetect Diagnostics Secures $75M Funding for Global Expansion of Handheld Devices
AccuDetect Diagnostics successfully closed a $75 million Series B funding round, earmarked for accelerating the global market penetration and manufacturing scale-up of its innovative handheld diagnostic devices for chronic disease management.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $10.0 Bn |
| Market Size (Forecast) | $20.6 Bn |
| CAGR | 7.5% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 21 Countries |
| Segments Covered | 6 Segments, 44 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included